Fintel reports that on May 27, 2026, UBS upgraded their outlook for BioNTech SE - Depositary Receipt (NasdaqGS:BNTX) from ...

Looking ahead to 2030, our model projects BNTX could trade at an average price of $225.58, with a potential range between $169.18 and $281.97. This represents a potential 141.4% return from today's ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The confirmed overall response rate (cORR) for patients with squamous non-small cell lung cancer hit 68.4% when pumitamig was combined with chemotherapy — but the most striking figure came from a ...

The show of hands at this year's ASCO annual meeting is unmistakable. BioNTech is presenting more than 25 clinical studies in Chicago, including 13 pivotal trials — an extraordinary concentration of ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...